Miriam Kidron is CSO at ORAMED PHARMACEUTICALS INC. (ORMP). They have made 6 open-market trades across 1 company since 2014, most recently 2026-09-24.
CIK 0001409232
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 6 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ORMP | SELL | 2023-03-14 | 2023-03-15 | $2.01 | $402K | +5.4% | +9.3% | +94.6% |
| ORMP | SELL | 2017-08-02 | 2017-08-03 | $8.50 | $762K | -1.7% | +9.0% | +16.5% |
| ORMP | SELL | 2017-04-19 | 2017-04-19 | $6.33 | $669K | +18.5% | +32.1% | +32.9% |
| ORMP | SELL | 2015-12-28 | 2015-12-31 | $8.90 | $445K | -20.4% | -26.0% | -20.0% |
| ORMP | SELL | 2014-09-10 | 2014-09-12 | $8.41 | $267K | -20.4% | -0.1% | -0.1% |
| ORMP | SELL | 2014-04-01 | 2014-04-03 | $12.03 | $1.7M | -20.4% | -0.1% | -0.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.